Beta Drugs Limited (BETA)
Beta Drugs Limited allotted 283,668 equity shares on April 25, 2026, via a preferential issue. This increased the company's paid-up capital to ₹10.42 crores, with shares issued at ₹1,712.49 each to 33 investors.
Apr 25 2026 14:04:00
Beta Drugs Limited (BETA)
Beta Drugs' board approved the allotment of 2,83,668 equity shares. These shares, priced at ₹1,712.49 each (including a premium of ₹1,702.49), are issued to facilitate the acquisition of Nivian Lifesciences Private Limited.
Apr 25 2026 13:04:00
Beta Drugs Limited (BETA)
Beta Drugs expands international market access with key regulatory milestones in Azerbaijan and the Philippines. The company expects GMP approval in 1-2 months for Azerbaijan and secured product registrations for 2 generic brands in the Philippines, strengthening export sales.
Apr 22 2026 09:04:00
Beta Drugs Limited (BETA)
Beta Drugs expands international market access with key regulatory milestones in Azerbaijan and the Philippines. The company expects GMP approval in 1-2 months for Azerbaijan and secured product registrations for 2 generic brands in the Philippines, strengthening export sales.
Apr 22 2026 09:04:00
Beta Drugs Limited (BETA)
Beta Drugs clarified significant share price movement. The company confirmed no undisclosed price-sensitive information and stated the movement is purely market-driven.
Apr 07 2026 10:04:00
Beta Drugs Limited (BETA)
Beta Drugs clarified its shareholding pattern after a preferential issue, with promoter holding decreasing from 64.63% to 59.10%. Institutional investors increased their stake from 3.43% to 9.14%. The clarification addresses observations from NSE regarding an Extra Ordinary General Meeting notice.
Apr 03 2026 10:04:00
Beta Drugs Limited (BETA)
Beta Drugs clarified its shareholding pattern after a preferential issue, with promoter holding decreasing from 64.63% to 59.10%. Institutional investors increased their stake from 3.43% to 9.14%. The clarification addresses observations from NSE regarding an Extra Ordinary General Meeting notice.
Apr 03 2026 10:04:00
Read More